- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03116035
Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-Making
June 8, 2023 updated by: University of Wisconsin, Madison
A Randomized Controlled Trial Evaluating the Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-Making
This is a prospective randomized control trial to compare the impact of two different types of pre-operative web-based breast cancer information on the quality of patient decision making.
Patients are emailed web-based information prior to the surgical consultation.
Outcomes are assess at multiple time points: 1) prior to the surgical consultation, 2) immediately following the consultation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
244
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
- >18 years of age
- Newly diagnosed stage 0-3 breast cancer
- English speaking
- Has an email address
- No prior recent contact with the breast surgeon
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Web-based decision aid
A commercially available web-based breast cancer surgery decision aid
|
Patients were randomized to receive links to a commercially available decision aid.
|
|
Active Comparator: Standard websites
selected, high-quality standard web-sites
|
Patients were randomized to receive links to standard, high-quality websites.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Knowledge using the Breast Cancer Decision Quality Instrument
Time Frame: immediately prior to the surgical consultation
|
immediately prior to the surgical consultation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Decisional concordance using the Breast Cancer Decision Quality Instrument
Time Frame: immediately prior to the surgical consultation
|
immediately prior to the surgical consultation
|
|
Perceived communication with the breast surgeon using the Breast Cancer Decision Quality Instrument
Time Frame: following the surgical consultation but prior to the surgery
|
following the surgical consultation but prior to the surgery
|
|
Breast surgeon and staff (nurse, mid-level provider) assessment of how the web-based decision aid versus standard high-quality breast cancer websites influenced their patient interactions, based on Practitioner Opinion Survey
Time Frame: at completion of patient accrual, estimated to be 2 years after initiating study
|
at completion of patient accrual, estimated to be 2 years after initiating study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 24, 2014
Primary Completion (Actual)
June 28, 2016
Study Completion (Actual)
June 28, 2016
Study Registration Dates
First Submitted
April 3, 2017
First Submitted That Met QC Criteria
April 12, 2017
First Posted (Actual)
April 14, 2017
Study Record Updates
Last Update Posted (Actual)
June 12, 2023
Last Update Submitted That Met QC Criteria
June 8, 2023
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-1500
- UW13089 (Other Identifier: UWCCC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Web-based decision aid
-
National Taiwan University HospitalRecruitingInfertility, Female | Female InfertilityTaiwan
-
Agency for Healthcare Research and Quality (AHRQ)Completed
-
National Taipei University of Nursing and Health...RecruitingShared Decision Making | Vaginal Birth After CesareanTaiwan
-
Stanford UniversityNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Agency for Healthcare Research and Quality...Active, not recruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage 0United States, Guam, Puerto Rico
-
Laval UniversityNot yet recruiting
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsEnrolling by invitationGender Dysphoria | Transgender Persons | Transsexualism | Transgenderism | Gender Incongruence | Phalloplasty | Gender Dysphoria, AdultUnited States
-
China Medical University HospitalRecruitingRenal Replacement Therapy | End-stage Renal Disease | Decision Aid | Decision-makingTaiwan
-
University of SaskatchewanSaskatchewan Health Research FoundationCompleted
-
Rhode Island HospitalAgency for Healthcare Research and Quality (AHRQ)Unknown